Parkinson’s disease does not directly cause strokes, but it significantly increases the risk of having one. A large population-based study found that people with Parkinson’s were about 2.4 times more likely to have an ischemic stroke (the type caused by a blocked blood vessel) compared to people without the disease. The relationship is complex, involving changes to blood vessels, medication side effects, and cardiovascular complications that accumulate over time.
How Parkinson’s Raises Stroke Risk
Several overlapping mechanisms connect Parkinson’s disease to a higher chance of stroke. None of them are as simple as “Parkinson’s blocks an artery,” but together they create a vascular environment where strokes become more likely.
Parkinson’s involves chronic inflammation throughout the nervous system, and that inflammation doesn’t stay confined to the brain areas responsible for movement. Research shows it extends to the tiny blood vessels in the brain, damaging the protective barrier between the bloodstream and brain tissue. In animal models of Parkinson’s, this barrier starts leaking even before movement symptoms appear. Over time, the walls of small blood vessels degrade, new vessels form abnormally, and existing ones regress. All of this weakens the brain’s vascular infrastructure.
The autonomic nervous system, which controls involuntary functions like heart rate and blood pressure, is also disrupted early in Parkinson’s. This disruption leads to orthostatic hypotension, where blood pressure drops sharply when standing up. Those repeated swings in blood pressure reduce blood supply to the brain and are themselves a recognized risk factor for stroke.
The Medication Factor
Levodopa, the most widely used treatment for Parkinson’s motor symptoms, introduces its own cardiovascular risk. The way the body processes levodopa generates a byproduct called homocysteine, and people on levodopa have notably higher levels of it. One study measured average homocysteine at 15.1 µmol/L in Parkinson’s patients on levodopa, compared to 11.5 µmol/L in healthy controls. That matters because elevated homocysteine is a well-established risk factor for cardiovascular disease, including stroke.
Higher homocysteine levels correlate with increased stiffness in the aorta, the body’s largest artery. Stiffer arteries mean the heart has to work harder to push blood through, and the vessels themselves become less able to absorb pressure changes. This stiffness is an independent predictor of stroke, heart failure, and kidney disease. So while levodopa effectively manages tremor and movement problems, it quietly contributes to vascular wear over years of use.
Atrial Fibrillation: A Hidden Link
Atrial fibrillation, an irregular heart rhythm that is one of the strongest known risk factors for stroke, occurs more frequently in people with Parkinson’s. A study of over 57,000 Parkinson’s patients in South Korea found that the incidence of new atrial fibrillation was about 37% higher in the Parkinson’s group than in matched controls (10.75 versus 7.86 cases per 1,000 person-years). Parkinson’s was confirmed as an independent risk factor for developing this arrhythmia even after accounting for other health conditions.
The connection likely traces back to autonomic nervous system dysfunction. The autonomic system plays a central role in regulating heart rhythm, and because Parkinson’s progressively damages autonomic nerve pathways, the heart becomes more vulnerable to electrical misfiring. Younger Parkinson’s patients appeared to face a disproportionately elevated risk. Those between ages 40 and 49 had roughly three times the risk of developing atrial fibrillation compared to their peers without Parkinson’s.
What the Numbers Show
A meta-analysis combining data from 9 cohort studies and 2 case-control studies confirmed that Parkinson’s increases overall stroke risk. The most detailed individual study, which used propensity score matching to compare similar patients with and without Parkinson’s, reported a hazard ratio of 2.37 for ischemic stroke. In practical terms, that means Parkinson’s patients in the study developed ischemic strokes at well over twice the rate of their matched counterparts, and the stroke-free survival rate was significantly lower in the Parkinson’s group across the entire follow-up period.
This elevated risk was specific to ischemic strokes, which account for roughly 87% of all strokes and occur when a clot or plaque blocks blood flow to part of the brain. The evidence for hemorrhagic stroke (caused by bleeding) is less clear-cut.
Vascular Parkinsonism: When Stroke Mimics Parkinson’s
Adding to the confusion between these two conditions, strokes can actually cause symptoms that look like Parkinson’s disease. This is called vascular parkinsonism, and it typically develops after small strokes damage movement-control areas deep in the brain. It accounts for a meaningful percentage of parkinsonism cases, particularly in older adults.
Vascular parkinsonism looks different from typical Parkinson’s in several ways. It tends to affect the lower body more, causing walking difficulties and balance problems rather than the classic hand tremor. Symptoms usually appear on both sides of the body rather than starting on one side. People with vascular parkinsonism are more likely to experience falls, urinary incontinence, difficulty swallowing, and cognitive decline. They also respond poorly to levodopa, which is one of the key clinical clues that distinguishes the two conditions. The onset is generally later in life, and the progression can be more stepwise, worsening suddenly with each new small stroke rather than declining gradually.
Managing Vascular Risk With Parkinson’s
Because the stroke risk in Parkinson’s comes from multiple directions, managing it means paying attention to several things at once. Blood pressure monitoring matters more than usual, especially tracking for large drops when standing. If you or someone you care for has Parkinson’s, keeping tabs on standard cardiovascular risk factors like cholesterol, blood sugar, and weight remains important, perhaps more so than in the general population given the added vascular burden.
Homocysteine levels can be checked with a simple blood test. B vitamins, particularly folate and B12, help the body clear homocysteine, and some neurologists monitor these levels in patients on long-term levodopa therapy. Heart rhythm irregularities deserve attention too, since the elevated atrial fibrillation risk means that symptoms like palpitations, unexplained dizziness, or unusual fatigue warrant a cardiac evaluation. Catching atrial fibrillation early allows for treatment that substantially reduces stroke risk.